Histopathological evaluation of the nervous system in national toxicology program rodent studies: A modified approach

Toxicologic Pathology

Volumn 39, Issue 3, 2011, Pages 463-470

  Rao, Deepa B ^a,b   Little, Peter B ^c   Malarkey, David E ^a   Herbert, Ronald A ^a   Sills, Robert C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b INTEGRATED LABORATORY SYSTEMS   (United States)

^c CHARLES RIVER LABORATORIES   (United States)

Author keywords

brain; histopathology; nervous system; neuropathology; NTP; screening

Indexed keywords

1,2 DIETHYLBENZENE; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 ACETYLPYRIDINE; 3 NITROPROPIONIC ACID; ACETIC ACID; ACRYLAMIDE; ANTIINFECTIVE AGENT; BENZENE DERIVATIVE; CARCINOGEN; COBALT; CUPRIZONE; DIBROMOACETIC ACID; ETHYLENE OXIDE; GLYCIDOL; MANEB; MANGANESE; NAPHTHALENE; NEUROTOXIN; OXIDOPAMINE; PARAQUAT; PESTICIDE; PILOCARPINE; PYRIDOXINE; ROTENONE; TAXANE DERIVATIVE; TRIMETHYLTIN; UNCLASSIFIED DRUG; URANIUM; ZALCITABINE;

ALZHEIMER DISEASE; AMYOTROPIC LATERAL SCLEROSIS; AREA POSTREMA; ARTICLE; AUTISM; AUTONOMIC GANGLION; AUTONOMIC NERVOUS SYSTEM; AXONAL INJURY; BASAL GANGLION; BRAIN; BRAIN DAMAGE; BRAIN TISSUE; BRAIN TUMOR; CANCER DIAGNOSIS; CARCINOGENICITY; CEREBELLUM; CEREBRAL PALSY; CERVICAL SPINAL CORD; CHEMICAL ANALYSIS; CHEMICAL INDUSTRY; CHEMICAL INJURY; DEGENERATIVE DISEASE; DEVELOPMENTAL DISORDER; DOG; DRUG INDUCED DISEASE; DRUG SCREENING; ENVIRONMENTAL EXPOSURE; EPILEPSY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HEALTH CARE COST; HIPPOCAMPUS; HISTOPATHOLOGY; HUNTINGTON CHOREA; HYPERVITAMINOSIS; HYPOGLOSSAL NUCLEUS; HYPOTHALAMUS; INFERIOR COLLICULUS; LUMBAR SPINAL CORD; MEDULLA OBLONGATA; MENTAL DEFICIENCY; MESENCEPHALON; MULTIPLE SCLEROSIS; NERVE PLEXUS; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPATHY; NEUROTOXICITY; NEUROTOXICOLOGY; NONHUMAN; OLFACTORY BULB; PARAQUAT POISONING; PARIETAL CORTEX; PARKINSON DISEASE; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; PONS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RODENT; SCIATIC NERVE; SENSITIVITY ANALYSIS; SENSORIMOTOR NEUROPATHY; SENSORY NERVE; SPINAL CORD; STRESS; SUBSTANTIA NIGRA; SUPERIOR COLLICULUS; THALAMUS; THORACIC SPINAL CORD; TIBIAL NERVE; TISSUE SECTION; TOXIC INHALATION; TOXICITY TESTING; TOXIN ANALYSIS; TRIGEMINAL NERVE; TRIGEMINUS GANGLION; TUMOR LOCALIZATION;

ANIMALS; BRAIN; CARCINOGENICITY TESTS; DISEASE MODELS, ANIMAL; MICE; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; NEURODEGENERATIVE DISEASES; NEUROLOGY; NEUROTOXICITY SYNDROMES; PERIPHERAL NERVES; RATS; SPINAL CORD; TOXICOLOGY; TRIGEMINAL GANGLION;

RODENTIA;

EID: 79955568736     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623311401044     Document Type: Article

References (79)

1. Altevogt B. M., Hanson S. L., Leshner A. I.. Autism and the environment: challenges and opportunities for research. Pediatrics. 2008 ; 121: 1225-29
2. Anderson W. A., Flumerfelt B. A.. A light and electron microscopic study of the effects of 3-acetylpyridine intoxication on the inferior olivary complex and cerebellar cortex. J Comp Neurol. 1980 ; 190: 157-74 (Pubitemid 10117185)
3. Argyriou A. A., Koltzenburg M., Polychronopoulos P., Papapetropoulos S., Kalofonos H. P.. Peripheral nerve damage associated with administration of taxanes in patients with cancer. Crit Rev Oncol Hematol. 2008 ; 66: 218-28
4. Armstrong D. D.. Neuropathology of Rett syndrome. Ment Retard Dev Disabil Res Rev. 2002 ; 8: 72-76 (Pubitemid 34606516)
5. Aschner M., Erikson K. M., Dorman D. C.. Manganese dosimetry: Species differences and implications for neurotoxicity. Crit Rev Toxicol. 2005 ; 35: 1-32 (Pubitemid 40179899)
6. Blumcke I.. Neuropathology of focal epilepsies: A critical review. Epilepsy Behav. 2009 ; 15: 34-39
7. Bolon B., Funk K. A., Sills R. C.. Introduction and commentary: "toxicologic neuropathology"-and a whole lot more! The 2010 Joint STP/IFSTP International Symposium on Toxicologic Pathology. Toxicologic Pathology. 2010 ;:
8. Bronstein J., Carvey P., Chen H., Cory-Slechta D., DiMonte D., Duda J., English P., Goldman S., Grate S., Hansen J., Hoppin J., Jewell S., Kamel F., Koroshetz W., Langston J. W., Logroscino G., Nelson L., Ravina B., Rocca W., Ross G. W., Schettler T., Schwarzschild M., Scott B., Seegal R., Singleton A., Steenland K., Tanner C. M., Van Den Eeden S., Weisskopf M.. Meeting report: Consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environ Health Perspect. 2009 ; 117: 117-21
9. Carlson J., Armstrong B., Switzer R. C., Ellison G.. Selective neurotoxic effects of nicotine on axons in fasciculus retroflexus further support evidence that this a weak link in brain across multiple drugs of abuse. Neuropharmacology. 2000 ; 39: 2792-98
10. Cavagnaro A. T. Sacramento, CA: California Health and Human Services Agency ; 2007 :
11. Cicchetti F., Drouin-Ouellet J., Gross R. E.. Environmental toxins and Parkinson's disease: What have we learned from pesticide-induced animal models?. Trends Pharmacol Sci. 2009 ; 30: 475-83
12. Colman J. R., Nowocin K. J., Switzer R. C., Trusk T. C., Ramsdell J. S.. Mapping and reconstruction of domoic acid-induced neurodegeneration in the mouse brain. Neurotoxicol Teratol. 2005 ; 27: 753-67 (Pubitemid 41476334)
13. Cory-Slechta D. A., Thiruchelvam M., Richfield E. K., Barlow B. K., Brooks A. I.. Developmental pesticide exposures and the Parkinson's disease phenotype. Birth Defects Res A Clin Mol Teratol. 2005 ; 73: 136-39 (Pubitemid 40478237)
14. Cremer J. E., Cunningham V. J., Seville M. P.. Relationships between extraction and metabolism of glucose, blood flow, and tissue blood volume in regions of rat brain. J Cereb Blood Flow Metab. 1983 ; 3: 291-302 (Pubitemid 13017777)
15. Curia G., Longo D., Biagini G., Jones R. S., Avoli M.. The pilocarpine model of temporal lobe epilepsy. J Neurosci Methods. 2008 ; 172: 143-57
16. da Conceicao F. S., Ngo-Abdalla S., Houzel J. C., Rehen S. K.. Murine model for Parkinson's disease: From 6-OH dopamine lesion to behavioral test. J Vis Exp. 2010 ; 35: 1376
17. Dalakas M. C., Semino-Mora C., Leon-Monzon M.. Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2′3′-dideoxycytidine (ddC). Lab Invest. 2001 ; 81: 1537-44 (Pubitemid 33064279)
18. Davey J. C., Nomikos A. P., Wungjiranirun M., Sherman J. R., Ingram L., Batki C., Lariviere J. P., Hamilton J. W.. Arsenic as an endocrine disruptor: Arsenic disrupts retinoic acid receptor- and thyroid hormone receptor-mediated gene regulation and thyroid hormone-mediated amphibian tail metamorphosis. Environ Health Perspect. 2008 ; 116: 165-72 (Pubitemid 351356721)
19. Dickson D. W., Braak H., Duda J. E., Duyckaerts C., Gasser T., Halliday G. M., Hardy J., Leverenz J. B., Del Tredici K., Wszolek Z. K., Litvan I.. Neuropathological assessment of Parkinson's disease: Refining the diagnostic criteria. Lancet Neurol. 2009 ; 8: 1150-57
20. Dorman D. C., Struve M. F., Marshall M. W., Parkinson C. U., James R. A., Wong B. A.. Tissue manganese concentrations in young male rhesus monkeys following subchronic manganese sulfate inhalation. Toxicol Sci. 2006 ; 92: 201-10 (Pubitemid 43985802)
21. Faingold C. L., Gehlbach G., Caspary D. M. Neurobiology of Hearing: The Central Auditory System. Altschuler R. A., ed. New York: Raven Press, Ltd ; 1991: 223-52.
22. Folkerth R. D.. Neuropathologic substrate of cerebral palsy. J Child Neurol. 2005 ; 20: 940-49
23. Gagnaire F., Ensminger A., Marignac B., De Ceaurriz J.. Possible involvement of 1,2-diacetylbenzene in diethylbenzene-induced neuropathy in rats. J Appl Toxicol. 1991 ; 11: 261-68
24. Ganz M. Understanding Autism: From Basic Neuroscience to Treatment. Moldin S.O. Rubenstein J. L. R., ed. Boca Raton: CRC Press ; 2006: 475-502.
25. Garman R. H.. Evaluation of large-sized brains for neurotoxic endpoints. Toxicol Pathol. 2003 ; 31 Suppl: 32-43 (Pubitemid 36169402)
26. Garman R. H., Snellings W. M., Maronpot R. R.. Brain tumors in F344 rats associated with chronic inhalation exposure to ethylene oxide. Neurotoxicology. 1985 ; 6: 117-37 (Pubitemid 15122271)
27. Garman R. H., Snellings W. M., Maronpot R. R.. Frequency, size and location of brain tumours in F-344 rats chronically exposed to ethylene oxide. Food Chem Toxicol. 1986 ; 24: 145-53 (Pubitemid 16167140)
28. Grabiec M., Turlejski K., Djavadian R.. Reduction of the number of new cells reaching olfactory bulbs impairs olfactory perception in the adult opossum. Acta Neurobiol Exp (Wars). 2009 ; 69: 168-76
29. Grandjean P., Landrigan P. J.. Developmental neurotoxicity of industrial chemicals. Lancet. 2006 ; 368: 2167-78 (Pubitemid 44894541)
30. Hattori N., Sato S.. Animal models of Parkinson's disease: Similarities and differences between the disease and models. Neuropathology. 2007 ; 27: 479-83 (Pubitemid 47459722)
31. Hilkens P. H., Verweij J., Stoter G., Vecht C. J., van Putten W. L., van den Bent M. J.. Peripheral neurotoxicity induced by docetaxel. Neurology. 1996 ; 46: 104-8 (Pubitemid 26156111)
32. Hoover D. M., Carlton W. W.. The subacute neurotoxicity of excess pyridoxine HCl and clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) in beagle dogs. II. Pathology. Vet Pathol. 1981 ; 18: 757-68 (Pubitemid 12195127)
33. Honeycutt A., Grosse S., Dunlap L., Chen H., al Homsi G., Schendel D. Using Survey Data to Study Disability: Results from the National Health Interview Survey on Disability. Altman B. M. Barnartt S. N. Hendershot G. Larson S., ed. London, England: Elselvier Science Ltd ; 2003: 207-228.
34. Ishida N., Akaike M., Tsutsumi S., Kanai H., Masui A., Sadamatsu M., Kuroda Y., Watanabe Y., McEwen B. S., Kato N.. Trimethyltin syndrome as a hippocampal degeneration model: Temporal changes and neurochemical features of seizure susceptibility and learning impairment. Neuroscience. 1997 ; 81: 1183-91 (Pubitemid 27421778)
35. Jett D. A.. Finding new cures for neurological disorders: A possible fringe benefit of biodefense research?. Sci Transl Med. 2010 ; 2: 23ps12
36. Kato S.. Amyotrophic lateral sclerosis models and human neuropathology: Similarities and differences. Acta Neuropathol. 2008 ; 115: 97-114 (Pubitemid 50003823)
37. Krinke G., Schaumburg H. H., Spencer P. S., Suter J., Thomann P., Hess R.. Pyridoxine megavitaminosis produces degeneration of peripheral sensory neurons (sensory neuronopathy) in the dog. Neurotoxicology. 1981 ; 2: 13-24 (Pubitemid 12210511)
38. Levine T. E., Butcher R. E.. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group IV report: Triggers for developmental neurotoxicity testing. Neurotoxicol Teratol. 1990 ; 12: 281-84 (Pubitemid 20344193)
39. LoPachin R. M., Ross J. F., Lehning E. J.. Nerve terminals as the primary site of acrylamide action: A hypothesis. Neurotoxicology. 2002 ; 23: 43-59 (Pubitemid 36559697)
40. Mamounas L. A., Mullen C. A., O'Hearn E., Molliver M. E.. Dual serotoninergic projections to forebrain in the rat: Morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J Comp Neurol. 1991 ; 314: 558-86
41. Mayeux R.. Dissecting the relative influences of genes and the environment in Alzheimer's disease. Ann Neurol. 2004 ; 55: 156-58 (Pubitemid 38166989)
42. McCormack A. L., Thiruchelvam M., Manning-Bog A. B., Thiffault C., Langston J. W., Cory-Slechta D. A., Di Monte D. A.. Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis. 2002 ; 10: 119-27 (Pubitemid 34775465)
43. Mittal S., Ganesh S.. Protein quality control mechanisms and neurodegenerative disorders: Checks, balances and deadlocks. Neurosci Res. 2010 ; 68: 159-66
44. Monleau M., Bussy C., Lestaevel P., Houpert P., Paquet F., Chazel V.. Bioaccumulation and behavioural effects of depleted uranium in rats exposed to repeated inhalations. Neurosci Lett. 2005 ; 390: 31-36 (Pubitemid 41317785)
45. Morgan D. L., Little P. B., Herr D. W., Moser V. C., Collins B., Herbert R., Johnson G. A., Maronpot R. R., Harry G. J., Sills R. C.. Neurotoxicity of carbonyl sulfide in F344 rats following inhalation exposure for up to 12 weeks. Toxicol Appl Pharmacol. 2004 ; 200: 131-45 (Pubitemid 39346020)
46. Moser V. C., Phillips P. M., Levine A. B., McDaniel K. L., Sills R. C., Jortner B. S., Butt M. T.. Neurotoxicity produced by dibromoacetic acid in drinking water of rats. Toxicol Sci. 2004 ; 79: 112-22 (Pubitemid 38660255)
47. Techinal Report Series National Institutes of Health. Research Triangle Park, NC: ; 2000 :
48. Paxinos G. The Rat Nervous System. San Diego, CA: Academic Press ; 1995 :
49. Pelham W. E., Foster E. M., Robb J. A.. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. J Pediatr Psychol. 2007 ; 32: 711-27 (Pubitemid 47356048)
50. Perl D. P.. Neuropathology of Alzheimer's disease. Mt Sinai J Med. 2010 ; 77: 32-42
51. Persson E., Henriksson J., Tjalve H.. Uptake of cobalt from the nasal mucosa into the brain via olfactory pathways in rats. Toxicol Lett. 2003 ; 145: 19-27 (Pubitemid 38366126)
52. Prayson R. A.. Diagnostic challenges in the evaluation of chronic epilepsy-related surgical neuropathology. Am J Surg Pathol. 2010 ; 34: e1-13
53. Ramaswamy S., McBride J. L., Kordower J. H.. Animal models of Huntington's disease. ILAR J. 2007 ; 48: 356-73 (Pubitemid 350194368)
54. Richfield E. K., Thiruchelvam M. J., Cory-Slechta D. A., Wuertzer C., Gainetdinov R. R., Caron M. G., Di Monte D. A., Federoff H. J.. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Exp Neurol. 2002 ; 175: 35-48 (Pubitemid 34507908)
55. Roe D., Pease K. F., Silbergeld E. Environmental Defense Fund, New York: ; 1997 :
56. Sabri M. I., Hashemi S. B., Lasarev M. R., Spencer P. S.. Axonopathy-inducing 1,2-diacetylbenzene forms adducts with motor and cytoskeletal proteins required for axonal transport. Neurochem Res. 2007 ; 32: 2152-59 (Pubitemid 350059859)
57. Sakurada O., Kennedy C., Jehle J., Brown J. D., Carbin G. L., Sokoloff L.. Measurement of local cerebral blood flow with iodo [14C] antipyrine. Am J Physiol. 1978 ; 234: H59-66
58. Scremin O. U. The Rat Nervous System. Paxinos G., ed. San Diego, CA: Academic Press ; 1985: 3-35.
59. Brain Facts A Primer on the Brain and Nervous System. In Neural Disorders:Advances and Challenges. Society of Neuroscience. 2005 ;:
60. Sills R. C., Hailey J. R., Neal J., Boorman G. A., Haseman J. K., Melnick R. L.. Examination of low-incidence brain tumor responses in F344 rats following chemical exposures in National Toxicology Program carcinogenicity studies. Toxicol Pathol. 1999 ; 27: 589-99 (Pubitemid 29446828)
61. Sills R. C., Morgan D. L., Herr D. W., Little P. B., George N. M., Ton T. V., Love N. E., Maronpot R. R., Johnson G. A.. Contribution of magnetic resonance microscopy in the 12-week neurotoxicity evaluation of carbonyl sulfide in Fischer 344 rats. Toxicol Pathol. 2004 ; 32: 501-10 (Pubitemid 39258454)
62. Smeyne R. J., Jackson-Lewis V.. The MPTP model of Parkinson's disease. Brain Res Mol Brain Res. 2005 ; 134: 57-66 (Pubitemid 40409495)
63. Sokoloff L.. Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose. J Cereb Blood Flow Metab. 1981 ; 1: 7-36 (Pubitemid 11026196)
64. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M. H., Patlak C. S., Pettigrew K. D., Sakurada O., Shinohara M.. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977 ; 28: 897-916 (Pubitemid 8098854)
65. Spencer P. S. Experimental and Clinical Neurotoxicology. Spencer P. S. Schaumburg H. H., ed. New York: Oxford University Press ; 2000: 3-54.
66. Stadelmann C.. Recent advances in the neuropathology of multiple sclerosis. Rev Neurol (Paris). 2007 ; 163: 657-61 (Pubitemid 47015565)
67. Steenland K., MacNeil J., Vega I., Levey A.. Recent trends in Alzheimer disease mortality in the United States, 1999 to 2004. Alzheimer Dis Assoc Disord. 2009 ; 23: 165-70
68. Takahash H., Wakabayashi K.. The cellular pathology of parkinson's disease. Neuropathology. 2001 ; 21: 315-22 (Pubitemid 34130639)
69. Tanner C. M., Kamel F., Ross G. W., Hoppin J. A., Goldman S. M., Korell M., Marras C., Bhudhikanok G. S., Kasten M., Chade A. R., Comyns K., Richards M. B., Meng C., Priestley B., Fernandez H. H., Cambi F., Umbach D. M., Blair A., Sandler D. P., Langston J. W.. Rotenone, Paraquat and Parkinson's Disease. Environ Health Perspect.. 2011 ;:
70. Torkildsen O., Brunborg L. A., Myhr K. M., Bo L.. The cuprizone model for demyelination. Acta Neurol Scand Suppl. 2008 ; 188: 72-76 (Pubitemid 351606183)
71. (). http://www.epa.gov/opptintr/chemtest/
72. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: National Research Council ; 2000 :
73. Virgolini M. B., Chen K., Weston D. D., Bauter M. R., Cory-Slechta D. A.. Interactions of chronic lead exposure and intermittent stress: Consequences for brain catecholamine systems and associated behaviors and HPA axis function. Toxicol Sci. 2005 ; 87: 469-82 (Pubitemid 41300694)
74. von Deimling A., Krone W., Menon A. G.. Neurofibromatosis type 1: Pathology, clinical features and molecular genetics. Brain Pathol. 1995 ; 5: 153-62
75. Webster W. R. The Rat Nervous System. Paxinos G., ed. San Diego, CA: Academic Press ; 1995: 797-831.
76. Whetten-Goldstein K., Sloan F. A., Goldstein L. B., Kulas E. D.. A comprehensive assessment of the cost of multiple sclerosis in the United States. Mult Scler. 1998 ; 4: 419-25 (Pubitemid 28515352)
77. Willett W. C.. Balancing life-style and genomics research for disease prevention. Science. 2002 ; 296: 695-98 (Pubitemid 34441988)
78. Woodruff-Pak D. S.. Animal models of Alzheimer's disease: Therapeutic implications. J Alzheimers Dis. 2008 ; 15: 507-21
79. Yoon D., Frick K. D., Carr D. A., Austin J. K.. Economic impact of epilepsy in the United States. Epilepsia. 2009 ; 50: 2186-91